Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Pharmaceuticals market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

405 Item(s)

Page 1 of 41

  1. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2016

    By: GlobalData
    , Published: Dec-2016
    , Product code: GDPH0503QD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2016” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q3 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,500.00

  2. Partnerships, Licensing, Investments and M&A Deals and Trends for September 2016 in Pharmaceuticals

    By: GlobalData
    , Published: Nov-2016
    , Product code: GDPH0502MD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for September 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in September 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,000.00

  3. Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals

    By: GlobalData
    , Published: Oct-2016
    , Product code: GDPH0501MD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,000.00

  4. Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals

    By: GlobalData
    , Published: Sep-2016
    , Product code: GDPH0500MD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,000.00

  5. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2016

    By: GlobalData
    , Published: Aug-2016
    , Product code: GDPH0499QD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2016” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q2 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,500.00

  6. Partnerships, Licensing, Investments and M&A Deals and Trends for June 2016 in Pharmaceuticals

    By: GlobalData
    , Published: Aug-2016
    , Product code: GDPH0498MD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for June 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in June 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,000.00

  7. Partnerships, Licensing, Investments and M&A Deals and Trends for May 2016 in Pharmaceuticals

    By: GlobalData
    , Published: Jul-2016
    , Product code: GDPH0497MD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for May 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in May 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,000.00

  8. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2016

    By: GlobalData
    , Published: Jun-2016
    , Product code: GDPH0496QD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2016” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q1 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,500.00

  9. Partnerships, Licensing, Investments and M&A Deals and Trends for April 2016 in Pharmaceuticals

    By: GlobalData
    , Published: Jun-2016
    , Product code: GDPH0495MD
    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in April 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
    $1,000.00

  10. Global Licensing Partnering - May2016.pdf

    By: Current Partnering
    , Published: May-2016
    , Product code: CP2063
    The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies
    $2,995.00

405 Item(s)

Page 1 of 41